Global Bioreactors and Fermenters Market: Overview
Bioreactors and fermenters are mainly used in research institutes and bioprocessing industries. Bioreactors are employed for the cultivation of mammalian, plants, and insect cells, and for large scale production of pharmaceuticals, antibodies, vaccines, etc., or for the bioconversion of organic wastes. Fermenters are utilized for the growth and maintenance of a population of bacterial or fungal cells in a controlled mode. They are small as compared to bioreactors. This report analyzes the current and future prospects of the bioreactors and fermenters market based on product, process, end user and geography.
Request Brochure for Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15230
Global Bioreactors and Fermenters Market: Snapshot
Bioreactors and fermenters are used for creating proper environment for the growth of microorganisms or driving biochemically active substances derived from such organisms. Fermenters are basically utilized for the growth and maintenance of a population of bacterial or fungal cells in a controlled mode. Bioreactors, the large sized fermenters, are widely used in biopharmaceutical industry for the production of biologics such as monoclonal antibodies, recombinant proteins, and vaccines at a large scale.
In the past few years, the process of large-scale bio-manufacturing has become more practical owing to advancements in technology and the easy availability of machines large enough to produce significantly high volumes of biologics due to progress in expression systems, cell lines, and cultures. These advancements have boosted the requirement for equipment as demand for small volume and multi-product capabilities have enabled facilities to adjust unit operations based on demand without incurring wastages and additional expenses.
According to Transparency Market Research, the global bioreactors and fermenters market is projected to reach US$4461.0 mn in 2024 at a CAGR of 12.2% from 2016 to 2024.
Request for Analysis of COVID19 Impact on Bioreactors and Fermenters Market:
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=15230
Asia Pacific Market to Steer Ahead at Promising Growth Rate
From a geographical standpoint, developed regions North America and Europe commanded a clear dominance in the global bioreactors and fermenters market in2015, collectively accounting for a nearly 62% of the global market.
North America led the market in the said year, a feat chiefly attributable to the vast technological advancements achieved in the field of bioprocessing systems and the increased adoption of single-use disposable bioreactors. The North America marker for bioreactors and fermenters also has a strong hold on the global market owing to the presence of several biopharmaceutical companies and bioprocessing equipment manufacturers. Native companies such as Thermo Fischer Scientific Inc, GE Healthcare and Danaher Corporation have fuelled the demand for the bioreactors and fermenters in the region and are considered to keep the demand for bioreactors and fermenters strong in the next few years.
Over the report’s forecast period, however, the Asia Pacific market for bioreactors and fermenters is expected to be the market with the most promising growth rate. With several factors working in its favor, such as strengthening economies and funds being poured in by international biopharmaceutical companies and contract manufacturers aiming to exploit the vast growth opportunities that the region has to offer, the Asia Pacific market is likely to register a 14.3% CAGR from 2016 to 2024. The rising prevalence of chronic diseases and the resultant rise in demand for biologics are also driving the market for bioreactors and fermenters in Asia Pacific.
Key Players of Bioreactors and Fermenters market Report:
The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the bioreactors and fermenters market include Applikon Biotechnology B.V., Danaher Corporation, Eppendorf AG, Finesse Solutions, Inc., GE Healthcare, Merck KGaA, PBS Biotech, Inc., PIERRE GUERIN TECHNOLOGIES, Sartorius AG, SOLARIS BIOTECHNOLOGY srl, Thermo Fisher Scientific Inc and ZETA Holding GmbH. Acquisitions was the primary strategy adopted by the major market players to enter into the bioreactors and fermenters market. For instance, GE Healthcare acquired Xcellerex, Inc. in 2012, to establish its footprints in single-use bioreactors market.
Buy Bioreactors and Fermenters Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=15230<ype=S
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
